The Food and Drug Administration could fine people who break certain safety rules for human cell and tissue products. The bill would also expand education, publish oversight data, and seek ideas for updating the rules.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Shandra Eisenga Human Cell and Tissue Product Safety Act is a Senate bill in committee. The latest recorded action: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Latest action on H.R. 1082: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who this affects: This bill mainly affects patients, donors, health workers, and businesses that handle human cell and tissue products. Health workers would get more donation guidance. Businesses and clinics covered by the named safety rules could face new fines. Researchers, patients, and industry groups could also help shape future policy.
Why this matters: Poor screening, handling, or descriptions can make human cell and tissue products unsafe. Better training could help health workers guide patients and families. New fines may push clinics and companies to follow safety rules more closely. Public data may also show gaps in inspections or slow agency replies. Future rule changes could affect safety, costs, new treatments, and patient access, but their full effects would depend on how the agencies act.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: Shandra Eisenga Human Cell and Tissue Product Safety Act
The Food and Drug Administration could fine people who break certain safety rules for human cell and tissue products. The bill would also expand education, publish oversight data, and seek ideas for updating the rules.
Use this page to support, oppose, or ask Congress to amend H.R.1082. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in Health
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Latest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (6/24/2025)
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your senators when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Shandra Eisenga Human Cell and Tissue Product Safety Act, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around H.R.1082, your stance, and the reasons you choose, then lets you edit and send when ready.
